BP#HKEX RC2803I

HKEX Expected to Post Optimistic Results for 2025

HKEX's Derivatives Market Sees Average Daily Volume of 1.7 Million Contracts in January

HKEX Announces Strong Progress of the Swap Connect Mechanism

HK SFC Requires 13 Underwriters to Conduct Internal Reviews and Propose Resource Management Plans

HKCGI Loosens Secretarial Appointment Limits, SEHK Tightens Oversight

CICC Maintains HKEX's Target Price and Earnings Forecast

HKEX Signs Memorandum of Cooperation with Brazilian Stock Exchange

HKEX CEO Chen Yiting Advocates for Richer Products to Counter Competition

Hong Kong securities industry concerned about IPO underwriter market concentration

Hong Kong and Shanghai Gold Exchanges Sign Cooperation Memorandum, Advance Gold Market Collaboration

Deloitte Predicts HK Government Budget Surplus in 2025/26 and Proposes Suggestions for High-Quality Economic Development

BlackRock Increases Holdings in HKEX to 5.14%

Hong Kong Exchange Regulatory Actions: Strengthening Crackdown on Fake Accounts in IPO Market

UBS Predicts HKEX Q4 Net Profit to Fall Sequentially

Citibank Predicts HKEX Q4 2025 Earnings

Goldman Sachs Slightly Adjusts Hang Seng Exchange's Earnings Forecast and Target Price

HKEX Plans to Implement Second Phase Measures to Reduce Minimum Price Movement for Securities Trading

HKEX Plans to Lower Minimum Price Movement in 2026

JPMorgan Increases Holdings in HKEx H Shares to 7.07%

HKEX to Launch Six New Stock Option Categories on January 19, 2026

UNI PRINTSHOP

WING CHI HLDGS

CINESE INTL

WAN KEI GROUP

CHINA WACAN

JH EDUCATION

DIGITAL DOMAIN

LOTUS HORIZON

VICO INTL HLDGS

K W NELSON GP

00388

STAN

02888

Standard Chartered plc has submitted an updated director list to the Hong Kong Stock Exchange, effective February 10, 2026. The board is led by Non-executive Chair Maria da Conceicao das Neves Calha Ramos and Group Chief Executive William Thomas Winters, CBE. Key independent directors include Shirish Moreshwar Apte, Jacqueline Hunt, and others. The board oversees five committees, each chaired by different members, focusing on audit, risk, culture, remuneration, and governance.

Reuters

HKEX

Standard Chartered PLC

STANCHART

Standard Chartered Files Director List with HKEX

HKXCY

00HSI

03037

07300

03115

02800

07200

07500

The Hong Kong Stock Exchange (HKEX) has reported robust performance for newly listed stocks. According to Ming Pao, data from Dealogic and Bloomberg indicates that initial public offerings (IPOs) raising $100 million or more have seen significant gains. On average, these stocks experienced a 23.8% increase in share price on their first day of trading. Over the course of a month, the average increase reached 30.7%, marking the best performance in the past 20 years.

CoinLive

Hong Kong Exchanges and Clearing (HKEX)

Hang Seng Index

CSOP HSI ETF

FI CSOP HSI

ISHARESHSI

TRACKER FUND

FL2 CSOP HSI

ChinaAMC Hang Seng ETF

FI2 CSOP HSI

GF Fund CSI HK Connect Financials(ex Banks) Thematic ETF

China Southern Hang Seng ETF

Hong Kong Stock Exchange Reports Strong IPO Performance

HKEX:TRADING IN SHARES OF CHINA NT PHARMA GROUP COMPANY HAS BEEN HALTED ON FEB 10

China Merchants CSI Biotechnology Theme ETF

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

ChinaAMC SSE STAR Biology and Medicine ETF

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

Proshares Ultra Nasdaq Biotech

iShares Biotechnology ETF

ChinaAMC SSE Health Care ETF Initiating Fund

E Fund CSI 300 Health Care ETF

China Universal 800 Health Care ETF

Direxion S&P Biotech Bear 3X

VG Health

ChinaAMC CSI Biotechnology Theme ETF

Penghua CSI HK Connect Health Care Composite ETF

E Fund Hang Seng SCHK Innovative Drug ETF

Bosera Hang Seng Health Care ETF(QDII)

iShares US Pharma

Ark Genomic Revolution ETF

Health Care Select Sector SPDR

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

iShares Global Healthcare

NT PHARMA

E Fund CSI Biotechnology Theme ETF

Yinhua CSI Innovative Drugs Industry ETF

Bosera Hang Seng SCHK Innovative Drug Select ETF

Guotai SSE STAR Brand Name Drug ETF

GF CSI HK Innovative Drugs Industry ETF(QDII)

Invesco Biotechnology & Genome ETF

ALPS Medical Breakthrough

Minsheng Royal CSI Biotechnology Theme ETF

VanEck Biotech ETF

First Trust NYSE Arca Biotech Index Fd

Guotai CSI Bio-medicine ETF

SPDR S&P Biotech

HKEX Says Trading In Shares Of China NT Pharma Group Company Halted

08403

Dowway Holdings Ltd. has submitted an updated director list to the Hong Kong Stock Exchange. The Board is led by Mr. Sun Wei, with Mr. Huang Xiaodi as CEO. Executive directors include Mr. Chen Xicheng, Mr. Shum Ngok Wa, and Ms. Wang Jinmei. Independent non-executive directors are Mr. Tam Chak Chi, Ms. Yau Yin Tan, and Ms. Zhou Yiyan, with various committee roles. This information is for informational purposes only and should not be considered financial or legal advice.

DOWWAY

Dowway Holdings Files Director List with HKEX

02675

Shenzhen Edge Medical Co. Ltd. has filed a next day disclosure with the Hong Kong Stock Exchange, indicating an increase of 323,602,948 shares. However, the specific issue price and details regarding the new shares were not disclosed. This filing is part of the company's regulatory obligations and aims to inform investors about changes in its issued shares.

EDGE MEDICAL-B

Shenzhen Edge Medical Files Next Day Disclosure Return to HKEX for Increase of 323,602,948 Shares at Undisclosed Price

02318

601318

The Hang Seng Index closed at 27,027 points, up 467 points or 1.8%. The Hang Seng TECH Index reported 5,417 points, up 71 points or 1.3%. The total market turnover was HKD 255.142 billion. Active heavyweight stocks performed as follows: Ping An rose 4.9%, HKEX rose 2.7%, Tencent rose 2.3%, and Alibaba rose 1.9%. Several stocks reached new highs, including Sun Hung Kai Properties, HSBC, YUM CHINA, Galaxy Entertainment Group, and Henderson Land

AASTOCKS

Galaxy Entertainment Group

Hang Seng TECH Index

YUM CHINA

PING AN

Alibaba

Tencent

Ping An

Ping An Insurance

GALAXY ENT

BABA-W

TENCENT

According to the "All-Day Express," the Hang Seng Index rose by 467 points; the Hang Seng TECH Index increased by 71 points. Ping An rose by over 4%. New World Development, HSBC Holdings, YUM CHINA, Galaxy Entertainment Group, and Henderson Land Development reached new highs with active trading

Minieye Technology Wins HKEX Approval for Hong Kong Share Full Circulation; Shares Jump 5%

marketscreener

Minieye Technology Wins HKEX Approval for Hong Kong Share Full Circulation; Shares Jump 5%

512880

512000

159842

03419

Hong Kong Exchanges and Clearing (HKEX) will announce last year's performance on February 26, expecting a full-year net profit between HKD 16.721 billion and HKD 17.346 billion, representing a year-on-year growth of 28.1% to 32.9%. Investors are focused on management's guidance regarding trading optimization, T+1 settlement, and other matters. The ratings and target prices from 9 brokerages for HKEX are as follows: Goldman Sachs Buy at HKD 550, DBS Buy at HKD 540, HSBC Buy at HKD 530, JP Morgan Overweight at HKD 530, Bank of America Buy at HKD 520, Morgan Stanley Overweight at HKD 508, Citigroup Buy at HKD 505, CICC Outperform at HKD 500, UBS Neutral at HKD 471

Guotai CSI All Share Investment Banking & Brokerage ETF

Hwabao WP CSI All Share Investment Banking & Brokerage ETF

ISHRS Us Brokers & Sec Exchg

Yinhua CSI All Share Investment Banking & Brokerage ETF

A GX HSICC

Investment Ratings and Target Prices for Hong Kong Exchanges and Clearing (Table)

HKEX expects its full-year net profit for 2025 to grow by 31.1% to HKD 17.151 billion, benefiting from a significant increase in Hong Kong stock trading volume. According to the forecasts of seven brokerages, HKEX's revenue for 2025 is expected to be between HKD 28.464 billion and HKD 29.098 billion, representing a year-on-year growth of 27.9%. Investors are focused on management's guidance regarding new stock listings and business reforms. Despite a substantial increase in trading revenue, investment income is expected to decline by 2%

FL2 CSOP HSCEI

"Qianzhan" Securities expect HKEX's net profit to increase by 31% last year, focusing on new stock listings and business reform guidelines

06865

HKEX: BLACKROCK'S LONG POSITION IN H-SHARES OF FLAT GLASS GROUP INCREASES TO 7.67% ON FEB 2 FROM 6.42%

BlackRock

FLAT GLASS

Blackrock's Long Position In H-Shares Of Flat Glass Group Increases To 7.67% On Feb 2 From 6.42% - HKEX

00992

HKEX:JPMORGAN CHASE & CO'S LONG POSITION IN LENOVO GROUP DECREASES TO 6.55% ON FEB 2 FROM 7.14%

Defiance Daily Target 2X Long JPM ETF

LENOVO GROUP

JPMorgan Chase

JPMorgan Chase & Co's Long Position In Lenovo Group Decreases To 6.55% On Feb 2 From 7.14% - HKEX

601899

01299

01810

00669

02899

Goldman Sachs released the latest Hong Kong stock buy list based on the "Earnings Revisions Leading Indicator" (ERLI), including AIA, XIAOMI-W, HKEX, Ping An, Zijin Mining, TECHTRONIC IND, and several other stocks

Zijin Mining

XIAOMI-W

TECHTRONIC IND

ZIJIN MINING

Goldman Sachs re-evaluates leading indicators (ERLI) and lists Hong Kong stock buy recommendations (Table)

HKEX posts market capitalisation for securities market for January

HKEX posts market capitalisation for securities market for January

UBS GROUP'S LONG POSITION IN H-SHARES OF ZIJIN MINING INCREASES TO 5.53% ON JAN 30 FROM 4.96% - HKEX

UBS Group AG

UBS Group's Long Position In H-Shares Of Zijin Mining Increases To 5.53% On Jan 30 - HKEX

Today’s Key News Recap

0203 | Dolphin Research Focus: Macro/Industry. In early trading, Hong Kong stocks plunged on unverified tax rumors about revising the High-Tech Enterprise qualification and raising tax rates for internet and gaming. Against the backdrop that VAT changes for the telecom sector have already taken effect, the chatter quickly spread.It triggered a broad selloff across HK tech, internet, and gaming. Valuations were hit in the short term, risk aversion spiked, and funds rotated to safety.Dolphin Research has issued a First Take on this. See 'China ADRs: Tax Hike Rumor — The rationale behind the false alarm'...

Webull

Tesla

Alphabet - C

Alphabet

HKEX-R

Uber Tech

Palantir Tech

EASTROC

EASTROC BEVERAGE

WEBULL CORPORATION C/WTS 10/04/2030(TO PUR COM)

Tax-hike rumors rattled the market; Dongpeng Beverage's debut was 'lukewarm' | Daily News Recap

0109 | Dolphin Research Focus. 🐬 Macro/Industry 1) HKEX announced it will add six stock options effective Jan 19, covering names such as Zijin Gold Intl, Laopu Gold, and Horizon Robotics.The additions broaden derivatives choices and offer more risk management tools. They should also help lift liquidity in the underlying names.🐬 Single Stock 1) $Taiwan Semiconductor(TSM.US) TSMC reported Dec revenue of NT$335.03bn, down 2.5% MoM but up 20.4% YoY. 2025 YTD revenue rose 31.6% YoY...

Apple

Taiwan Semiconductor

JD-SW

JD-SWR

JD HK SDR 10to1

JD.com

LAOPU GOLD

Laopu Gld HK SDR 50to1

Direxion Auspice Broad COM

TSM Q4 rev. seen >NT$1 tn; GOOGL integrates Gemini into Gmail | Daily News Recap

Baidu

Hot topic

Appraisal value

Long-rumored Kunlun Chip spin-off is now official as $Baidu(BIDU.US) announced it.On Jan 2, BIDU proposed to spin off Kunlun Chip Technology for an independent listing on the HKEX Main Board, while retaining control (59.45%).BIDU has filed confidentially, and the detailed prospectus is not yet public.Based on available information, Dolphin Research will first outline a few key questions.1. Kunlun Chip's origins and evolution? It traces back to BIDU's FPGA accelerator project launched in 2011...

BIDU-SWR

BIDU-SW

Baidu HK SDR 10to1

BIDU ADR US

Kunlun Chip IPO fast-tracks: Is BIDU's Google moment here?

1209 | Dolphin Research Focus: 🐬 Macro/Industry 1) Hong Kong Exchanges and Clearing Ltd. (HKEX) announced the HKEX Tech 100 Index, tracking the 100 largest Southbound Stock Connect-eligible tech names across six themes, including AI, biotech, and autonomous driving. The index fills a gap for a broad-based vehicle covering diversified China tech in HK and could attract more southbound flows.🐬 Single Stock 1) $NVIDIA(NVDA.US). Trump posted on Truth Social...

NVIDIA

Allianzim US Large Cap Buffer10 Mar ETF

HKEX debuts flagship Tech Index; NVDA H200 cleared for China exports | Daily News Recap

BP#HKEX RC2803I(55773.HK)